Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 13.0B
Gross Profit 3.6B 27.86%
Operating Income 1.1B 8.75%
Net Income 747.1M 5.74%
EPS (Diluted) $8.84

Balance Sheet Metrics

Total Assets 18.4B
Total Liabilities 10.3B
Shareholders Equity 8.1B
Debt to Equity 1.28

Cash Flow Metrics

Operating Cash Flow 1.7B
Free Cash Flow 1.1B

Revenue & Profitability Trend

Labcorp Holdings Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue13.0B12.2B11.9B13.1B14.0B
Cost of Goods Sold9.4B8.8B8.2B8.1B9.0B
Gross Profit3.6B3.4B3.7B5.0B5.0B
Operating Expenses2.2B2.0B1.8B1.7B1.7B
Operating Income1.1B1.1B1.8B3.1B2.9B
Pre-tax Income959.5M568.9M1.2B2.9B2.2B
Income Tax212.4M188.5M233.9M690.0M662.1M
Net Income747.1M419.2M1.3B2.4B1.6B
EPS (Diluted)$8.84$4.77$13.97$24.39$15.88

Income Statement Trend

Labcorp Holdings Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets4.8B3.8B4.6B5.3B5.1B
Non-Current Assets13.6B13.0B15.5B15.1B14.9B
Total Assets18.4B16.7B20.2B20.4B20.1B
Liabilities
Current Liabilities3.3B3.2B3.1B2.8B3.1B
Non-Current Liabilities7.0B5.6B7.0B7.3B7.5B
Total Liabilities10.3B8.8B10.0B10.1B10.6B
Equity
Total Shareholders Equity8.1B7.9B10.1B10.3B9.5B

Balance Sheet Composition

Labcorp Holdings Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income747.1M380.4M1.0B2.2B1.6B
Operating Cash Flow1.7B1.2B2.2B3.2B1.4B
Investing Activities
Capital Expenditures-----
Investing Cash Flow-876.9M-693.2M-1.2B-424.2M-261.5M
Financing Activities
Dividends Paid-243.1M-254.0M-195.2M00
Financing Cash Flow723.7M-1.6B-534.8M-2.1B-517.4M
Free Cash Flow1.1B874.1M1.5B2.7B1.8B

Cash Flow Trend

Labcorp Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 29.68
Forward P/E 16.17
Price to Book 2.61
Price to Sales 1.65
PEG Ratio 16.17

Profitability Ratios

Profit Margin 5.55%
Operating Margin 9.94%
Return on Equity 8.98%
Return on Assets 4.18%

Financial Health

Current Ratio 1.84
Debt to Equity 79.13
Beta 0.79

Per Share Data

EPS (TTM) $8.73
Book Value per Share $99.13
Revenue per Share $157.30

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lh21.7B29.682.618.98%5.55%79.13
Thermo Fisher 160.9B25.003.2613.70%15.19%69.23
Danaher 144.7B39.252.847.22%15.81%34.56
Idexx Laboratories 43.5B49.7430.1559.33%22.76%73.16
Agilent Technologies 34.4B29.885.6018.88%17.59%60.04
Iqvia Holdings 28.5B22.414.7921.64%8.61%242.91

Financial data is updated regularly. All figures are in the company's reporting currency.